Rhode Island SB 566: AN ACT RELATING TO STATE AFFAIRS AND GOVERNMENT -- THE RHODE ISLAND HEALTH CARE REFORM ACT OF 2004 -- HEALTH INSURANCE OVERSIGHT (Establishes a process whereby large drug manufacturers, may be penalized for prescription drug price increases where there is no, or inadequate, new evidence to support the price increase.)

Status: 04/04/2023 Committee recommended measure be held for further study (as of 2023-04-04)

State: Rhode Island · Session: 2023 · Bill: SB 566

Subjects: Health & Safety, Health Care Affordability, Pharmaceutical Assistance, Prescription drugs, State Affairs

Sponsors: DiMario, DiPalma, Euer, Lauria, Lawson, Miller, Murray, Pearson, Ujifusa, Valverde

View Rhode Island SB 566 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.